Summary
Amgen Inc. (AMGN) has filed an 8-K report detailing the execution of a Supplemental Indenture with LaSalle Bank National Association, acting as Trustee, on March 2, 2005. This amendment to the existing Indenture for Amgen's Liquid Yield Option Notes due 2032 introduces an additional purchase date for these notes on March 1, 2006. Holders of the notes can require Amgen to repurchase them at their accreted value, with the company having the flexibility to satisfy this obligation using cash, common stock, or a combination of both.
Key Highlights
- 1Amgen Inc. entered into a Supplemental Indenture on March 2, 2005, with LaSalle Bank National Association.
- 2The Supplemental Indenture amends the Indenture for Amgen's Liquid Yield Option Notes due 2032.
- 3An additional noteholder repurchase date has been established for March 1, 2006.
- 4Noteholders can demand repurchase of their securities at the accreted value of $747.01 per $1,000 principal amount at maturity.
- 5Amgen has the option to pay the repurchase price in cash, common stock, or a mix of both.
- 6This follows a significant repurchase of approximately $1.17 billion in principal amount of these notes on March 1, 2005.
- 7Approximately $2.36 billion principal amount at maturity of the Securities remain outstanding after the recent repurchase.